CTOs on the Move

QualChoice

www.qualchoice.com

 
QualChoice, our commitment is to your good health. Our vision is to become the health plan in this region that is most preferred by households, businesses, and the medical community.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.qualchoice.com
  • 10825 Financial Centre Pkwy
    Little Rock, AR USA 72211
  • Phone: 440.460.0093

Executives

Name Title Contact Details

Similar Companies

Schwabe North America

Schwabe North America is a Green Bay, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

World-Women To Respond-Disease

World-Women To Respond-Disease is a Oakland, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Valify

Drive tangible savings to your bottom line in weeks versus months using Valify, the only SaaS analytics and benchmarking tool for Purchased Services. Leave manual data aggregation behind. Automate the discovery of opportunity and begin tracking performance so your team can focus on realizing savings.

CMC Rescue Inc

When CMC Rescue was founded in 1978 our mission was to provide rescuers with a knowledgeable source for the specialized equipment they needed to do their jobs. Over the years we have grown to support a wide variety of rescue activities as a leading

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.